Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce G Pollock

Showing results (201-210 of 327) with videos related to

Pageof 33
Sort By:
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|October 18, 2016
Cognition and Dopamine D<sub>2</sub> Receptor Availability in the Striatum in Older Patients with SchizophreniaTarek K Rajji, Benoit H Mulsant, Shinichiro Nakajima, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 29, 2011
The ZNF804A gene: characterization of a novel neural risk mechanism for the major psychosesAristotle N Voineskos, Jason P Lerch, Daniel Felsky, et al.
British Journal of Clinical Pharmacology|February 3, 2022
MAP Bayesian modelling combining striatal dopamine receptor occupancy and plasma concentrations to optimize antipsychotic dose regimens in individual patientsMohamed Ismail, Thomas Straubinger, Hiroyuki Uchida, et al.
Journal of Affective Disorders|July 10, 2002
Course and rate of antidepressant response in the very oldAriel G Gildengers, Patricia R Houck, Benoit H Mulsant, et al.
Journal of Clinical Psychopharmacology|April 25, 2006
What is the optimal duration of a short-term antidepressant trial when treating geriatric depression?Benoit H Mulsant, Patricia R Houck, Ariel G Gildengers, et al.
NPJ Schizophrenia|May 1, 2019
Impaired illness awareness in schizophrenia and posterior corpus callosal white matter tract integrityPhilip Gerretsen, Tarek K Rajji, Parita Shah, et al.
JAMA Psychiatry|October 27, 2017
Extent of Dorsolateral Prefrontal Cortex Plasticity and Its Association With Working Memory in Patients With Alzheimer DiseaseSanjeev Kumar, Reza Zomorrodi, Zaid Ghazala, et al.
Journal of Clinical Pharmacology|January 7, 2011
Population pharmacokinetic modeling of ziprasidone in patients with schizophrenia from the CATIE studyAlette M Wessels, Robert R Bies, Bruce G Pollock, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 16, 2005
Development of a short form of the Severe Impairment BatteryJudith Saxton, Kari B Kastango, Laurence Hugonot-Diener, et al.
Journal of the American Geriatrics Society|May 31, 2008
Anticholinergic activity of 107 medications commonly used by older adultsMarci L Chew, Benoit H Mulsant, Bruce G Pollock, et al.
Pageof 33

Showing results (201-210 of 327) with videos related to

Sort By:
Pageof 33
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|October 18, 2016
Cognition and Dopamine D<sub>2</sub> Receptor Availability in the Striatum in Older Patients with SchizophreniaTarek K Rajji, Benoit H Mulsant, Shinichiro Nakajima, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 29, 2011
The ZNF804A gene: characterization of a novel neural risk mechanism for the major psychosesAristotle N Voineskos, Jason P Lerch, Daniel Felsky, et al.
British Journal of Clinical Pharmacology|February 3, 2022
MAP Bayesian modelling combining striatal dopamine receptor occupancy and plasma concentrations to optimize antipsychotic dose regimens in individual patientsMohamed Ismail, Thomas Straubinger, Hiroyuki Uchida, et al.
Journal of Affective Disorders|July 10, 2002
Course and rate of antidepressant response in the very oldAriel G Gildengers, Patricia R Houck, Benoit H Mulsant, et al.
Journal of Clinical Psychopharmacology|April 25, 2006
What is the optimal duration of a short-term antidepressant trial when treating geriatric depression?Benoit H Mulsant, Patricia R Houck, Ariel G Gildengers, et al.
NPJ Schizophrenia|May 1, 2019
Impaired illness awareness in schizophrenia and posterior corpus callosal white matter tract integrityPhilip Gerretsen, Tarek K Rajji, Parita Shah, et al.
JAMA Psychiatry|October 27, 2017
Extent of Dorsolateral Prefrontal Cortex Plasticity and Its Association With Working Memory in Patients With Alzheimer DiseaseSanjeev Kumar, Reza Zomorrodi, Zaid Ghazala, et al.
Journal of Clinical Pharmacology|January 7, 2011
Population pharmacokinetic modeling of ziprasidone in patients with schizophrenia from the CATIE studyAlette M Wessels, Robert R Bies, Bruce G Pollock, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 16, 2005
Development of a short form of the Severe Impairment BatteryJudith Saxton, Kari B Kastango, Laurence Hugonot-Diener, et al.
Journal of the American Geriatrics Society|May 31, 2008
Anticholinergic activity of 107 medications commonly used by older adultsMarci L Chew, Benoit H Mulsant, Bruce G Pollock, et al.
Pageof 33